PerkinElmer, Inc. (PKI): Price and Financial Metrics


PerkinElmer, Inc. (PKI)

Today's Latest Price: $84.32 USD

1.68 (-1.95%)

Updated Feb 27 12:00am

Add PKI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

PKI Stock Summary

  • With a one year PEG ratio of 436.58, Perkinelmer Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 90.3% of US stocks.
  • Perkinelmer Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.5% of US equities in our set.
  • The price/operating cash flow metric for Perkinelmer Inc is higher than 89.48% of stocks in our set with a positive cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Perkinelmer Inc are CAE, ELAN, WAT, HOLX, and ITT.
  • PKI's SEC filings can be seen here. And to visit Perkinelmer Inc's official web site, go to www.perkinelmer.com.
PKI Daily Price Range
PKI 52-Week Price Range

PKI Stock Price Chart More Charts


PKI Price/Volume Stats

Current price $84.32 52-week high $103.00
Prev. close $86.00 52-week low $78.35
Day low $83.63 Volume 1,015,100
Day high $87.72 Avg. volume 672,487
50-day MA $96.24 Dividend yield 0.33%
200-day MA $90.25 Market Cap 9.37B

PerkinElmer, Inc. (PKI) Company Bio


PerkinElmer Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The company was founded in 1931 and is based in Waltham, Massachusetts.

PKI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$84.32$26.16 -70%

Below please find a table outlining a discounted cash flow forecast for PKI, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Perkinelmer Inc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Perkinelmer Inc ended up being:

  • 81% of the company's capital comes from equity, which is greater than 59.31% of stocks in our cash flow based forecasting set.
  • The weighted average cost of capital for the company is 8. This value is greater than merely 18.73% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-70%
1%-70%
2%-70%
3%-69%
4%-69%
5%-69%

DHR, EW, GKOS, ZBH, and NEO can be thought of as valuation peers to PKI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


PKI Latest News Stream


Event/Time News Detail
Loading, please wait...

PKI Latest Social Stream


Loading social stream, please wait...

View Full PKI Social Stream

PKI Price Returns

1-mo -14.40%
3-mo -9.17%
6-mo 2.12%
1-year -10.18%
3-year 57.21%
5-year 83.48%
YTD -13.10%
2019 24.01%
2018 7.80%
2017 40.99%
2016 -2.12%
2015 23.21%

PKI Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PKI Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6206 seconds.